Abbott Labs (ABT) Offering Possible 21.65% Return Over the Next 5 Calendar Days

Abbott Labs’s most recent trend suggests a bearish bias. One trading opportunity on Abbott Labs is a Bear Call Spread using a strike $79.50 short call and a strike $84.50 long call offers a potential 21.65% return on risk over the next 5 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $79.50 by expiration. The full premium credit of $0.89 would be kept by the premium seller. The risk of $4.11 would be incurred if the stock rose above the $84.50 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for Abbott Labs is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for Abbott Labs is bearish.

The RSI indicator is at 54.82 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here

LATEST NEWS for Abbott Labs

Abbott and the Abbott Fund Support Relief Efforts for Cyclone Idai
Thu, 11 Apr 2019 19:16:00 +0000
ABBOTT PARK, Ill., April 11, 2019 /PRNewswire/ — Abbott (ABT) and its foundation, the Abbott Fund, are providing more than $500,000 in grants and healthcare products to support relief efforts for Cyclone Idai in Southeast Africa, including Mozambique, Malawi and Zimbabwe. According to the United Nations, significant aid is needed to help meet immediate needs across the region, following the devastating impact of Cyclone Idai and continued heavy rains and flooding. This includes focused efforts in Mozambique to address cholera, malaria and other diseases, as well as to meet immediate needs for food, water, shelter and medical care across the region.

Abbott (ABT) Earnings Expected to Grow: Should You Buy?
Wed, 10 Apr 2019 14:30:02 +0000
Abbott (ABT) doesn’t possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Abbott (ABT) Gains As Market Dips: What You Should Know
Tue, 09 Apr 2019 21:50:09 +0000
Abbott (ABT) closed at $78.67 in the latest trading session, marking a +0.19% move from the prior day.

The Abbott Laboratories (NYSE:ABT) Share Price Is Up 113% And Shareholders Are Boasting About It
Sat, 06 Apr 2019 14:01:30 +0000
Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card! The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put i…

AbbVie: High-Yield Dividend Aristocrat Offering a No-Fee DRIP
Fri, 05 Apr 2019 21:08:26 +0000
Dividend growth investing has proven to be one of the best ways for retail investors to accumulate wealth over the long term. One of the factors that boosts the wealth-creating power of dividend growth investing, is dividend reinvestment. Dividend reinvesting makes one’s share count rise, even if there is no additional principal invested into new shares.

Be Sociable, Share!

Related Posts